KRRO vs MS · rev $2.3M vs P/E 20, $344.27B cap
Korro Bio, Inc. (KRRO) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Korro Bio, Inc. (KRRO) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported KRRO revenue for 2024-12-31 was $2.3M. Net income was -$83.6M. KRRO currently screens at market cap $159.8M.
MS does not have a complete income-statement cache yet.
KRRO currently screens at market cap $159.8M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the KRRO and MS stock pages for the full models.
Not investment advice.